TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE (USD BILLION)
6.1. Topical Treatments
6.2. Systemic Treatments
6.3. Phototherapy
7. PSORIASIS TREATMENT MARKET, BY THERAPY CLASS (USD BILLION)
7.1. Biologics
7.2. Traditional Systemic Therapies
7.3. Topical Corticosteroids
7.4. Retinoids
7.5. Calcineurin Inhibitors
8. PSORIASIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
8.1. Topical
8.2. Oral
8.3. Injectable
8.4. Intravenous
9. PSORIASIS TREATMENT MARKET, BY PATIENT AGE GROUP (USD BILLION)
9.1. Pediatric
9.2. Adult
9.3. Geriatric
10. PSORIASIS TREATMENT MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Psoriasis Treatment Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Psoriasis Treatment Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. BristolMyers Squibb
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Merck
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Lilly
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Eli Lilly and Company
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Regeneron Pharmaceuticals
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Sanofi
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Celgene
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. AbbVie
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Gilead Sciences
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Amgen
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Johnson and Johnson
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Pfizer
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. UCB
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. AstraZeneca
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Novartis
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 8. US PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 9. US PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 10. US PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 11. US PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 28. UK PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 29. UK PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 30. UK PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 31. UK PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 58. APAC PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 59. APAC PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 60. APAC PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 61. APAC PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 128. MEA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 129. MEA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 130. MEA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 131. MEA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY THERAPY CLASS, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA PSORIASIS TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA PSORIASIS TREATMENT MARKET ANALYSIS
FIGURE 3. US PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 4. US PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 5. US PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 6. US PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 7. US PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 9. CANADA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 10. CANADA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 11. CANADA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 12. CANADA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE PSORIASIS TREATMENT MARKET ANALYSIS
FIGURE 14. GERMANY PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 15. GERMANY PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 16. GERMANY PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 17. GERMANY PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 18. GERMANY PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 20. UK PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 21. UK PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 22. UK PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 23. UK PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 25. FRANCE PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 26. FRANCE PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 27. FRANCE PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 28. FRANCE PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 30. RUSSIA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 31. RUSSIA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 32. RUSSIA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 33. RUSSIA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 35. ITALY PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 36. ITALY PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 37. ITALY PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 38. ITALY PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 40. SPAIN PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 41. SPAIN PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 42. SPAIN PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 43. SPAIN PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 45. REST OF EUROPE PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 46. REST OF EUROPE PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 47. REST OF EUROPE PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 48. REST OF EUROPE PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC PSORIASIS TREATMENT MARKET ANALYSIS
FIGURE 50. CHINA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 51. CHINA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 52. CHINA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 53. CHINA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 54. CHINA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 56. INDIA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 57. INDIA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 58. INDIA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 59. INDIA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 61. JAPAN PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 62. JAPAN PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 63. JAPAN PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 64. JAPAN PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 66. SOUTH KOREA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 67. SOUTH KOREA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 68. SOUTH KOREA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 69. SOUTH KOREA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 71. MALAYSIA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 72. MALAYSIA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 73. MALAYSIA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 74. MALAYSIA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 76. THAILAND PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 77. THAILAND PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 78. THAILAND PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 79. THAILAND PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 81. INDONESIA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 82. INDONESIA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 83. INDONESIA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 84. INDONESIA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 86. REST OF APAC PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 87. REST OF APAC PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 88. REST OF APAC PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 89. REST OF APAC PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA PSORIASIS TREATMENT MARKET ANALYSIS
FIGURE 91. BRAZIL PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 92. BRAZIL PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 93. BRAZIL PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 94. BRAZIL PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 95. BRAZIL PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 97. MEXICO PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 98. MEXICO PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 99. MEXICO PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 100. MEXICO PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 102. ARGENTINA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 103. ARGENTINA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 104. ARGENTINA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 105. ARGENTINA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 107. REST OF SOUTH AMERICA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 108. REST OF SOUTH AMERICA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 109. REST OF SOUTH AMERICA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 110. REST OF SOUTH AMERICA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA PSORIASIS TREATMENT MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 113. GCC COUNTRIES PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 114. GCC COUNTRIES PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 115. GCC COUNTRIES PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 116. GCC COUNTRIES PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 118. SOUTH AFRICA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 119. SOUTH AFRICA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 120. SOUTH AFRICA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 121. SOUTH AFRICA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA PSORIASIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 123. REST OF MEA PSORIASIS TREATMENT MARKET ANALYSIS BY THERAPY CLASS
FIGURE 124. REST OF MEA PSORIASIS TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 125. REST OF MEA PSORIASIS TREATMENT MARKET ANALYSIS BY PATIENT AGE GROUP
FIGURE 126. REST OF MEA PSORIASIS TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF PSORIASIS TREATMENT MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF PSORIASIS TREATMENT MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: PSORIASIS TREATMENT MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: PSORIASIS TREATMENT MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: PSORIASIS TREATMENT MARKET
FIGURE 133. PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2024 (% SHARE)
FIGURE 134. PSORIASIS TREATMENT MARKET, BY TREATMENT TYPE, 2019 TO 2032 (USD Billions)
FIGURE 135. PSORIASIS TREATMENT MARKET, BY THERAPY CLASS, 2024 (% SHARE)
FIGURE 136. PSORIASIS TREATMENT MARKET, BY THERAPY CLASS, 2019 TO 2032 (USD Billions)
FIGURE 137. PSORIASIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
FIGURE 138. PSORIASIS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2032 (USD Billions)
FIGURE 139. PSORIASIS TREATMENT MARKET, BY PATIENT AGE GROUP, 2024 (% SHARE)
FIGURE 140. PSORIASIS TREATMENT MARKET, BY PATIENT AGE GROUP, 2019 TO 2032 (USD Billions)
FIGURE 141. PSORIASIS TREATMENT MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. PSORIASIS TREATMENT MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
